Internal Medicine, Hematology & Oncology · Asheboro, NC
NPI
1043228836
Since 2006
Specialty
Internal Medicine, Hematology & Oncology
Code 207RH0003X
Group practices
1
Medicare group memberships
Hospitals
2
Hospital affiliations
713 S Fayetteville St, Suite B
Asheboro, NC, 27203
Phone (336) 626-0033
Groups this clinician bills Medicare through
Medicare paid, 2024
$32K
402 services
Medicare patients, 2024
155
Average age 75
Drug cost, 2024
$2.2M
855 prescriptions
Company payments, 2025
$677
From 19 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Dequincy A Lewis was code 99214 (office e&m - established), 151 times for 61 patients. In total Dequincy A Lewis billed 402 services in 10 codes, and Medicare paid $32K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2007-07-08.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99214 Office E&M - Established | Office | 151 | 61 | $80.53 | $12K |
| 99213 Office E&M - Established | Office | 146 | 95 | $50.10 | $7,315 |
| 99215 Office E&M - Established | Office | 67 | 40 | $119.96 | $8,037 |
| 99205 Office E&M - New | Office | 26 | 26 | $142.53 | $3,706 |
By year: 2022 $46K for 490 services; 2023 $42K for 459 services; 2024 $32K for 402 services.
Medicare prescription drug claims, 2024
In 2024, the drug Dequincy A Lewis prescribed most often to Medicare patients was Oxycodone Hcl, with 62 prescriptions and refills. In total Dequincy A Lewis wrote 855 Medicare prescriptions that cost $2.2M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Oxycodone Hcl Generic | 62 | 62 | 28 | $787 |
| Anastrozole Generic | 56 | 170 | 20 | $1,126 |
| Hydroxyurea Generic | 53 | 93 | 13 | $1,797 |
| Prednisone Generic | 41 | 49 | 20 | $85.05 |
| Prochlorperazine Maleate Generic | 41 | 41 | 30 | $438 |
| Imbruvica Ibrutinib | 38 | 38 | Under 11 | $554K |
| Letrozole Generic | 35 | 107 | 14 | $1,698 |
| Ondansetron Hcl Generic | 33 | 33 | 26 | $277 |
| Tamoxifen Citrate Generic | 26 | 78 | Under 11 | $753 |
| Dexamethasone Generic | 23 | 23 | 11 | $394 |
| Pregabalin Generic | 21 | 29 | Under 11 | $204 |
| Gabapentin Generic | 21 | 23 | Under 11 | $258 |
| Lenalidomide Generic | 19 | 19 | Under 11 | $270K |
| Hydrocodone-Acetaminophen Hydrocodone/Acetaminophen | 19 | 19 | Under 11 | $337 |
| Pemazyre Pemigatinib | 17 | 17 | Under 11 | $320K |
Brand drugs: 169 claims; generic drugs: 686 claims; opioid claims: 123.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Dequincy A Lewis $677 ($677 in general payments such as food, travel and fees) from 19 companies. The largest payer was E.R. Squibb & Sons, L.L.C. with $129.
| Company | Payments | Amount |
|---|---|---|
| E.R. Squibb & Sons, L.L.C. BMY | 7 | $129 |
| Pfizer Inc. PFE | 5 | $97 |
| Eisai Inc. 4523.T | 2 | $50.3 |
| Novartis Pharmaceuticals Corporation NVS | 2 | $46.3 |
| Merck Sharp & Dohme LLC MRK | 2 | $43.38 |
| BeOne Medicines USA, Inc. ONC | 2 | $41.94 |
| AstraZeneca Pharmaceuticals LP AZN | 2 | $40.26 |
| Regeneron Healthcare Solutions, Inc. REGN | 1 | $32.33 |
| TerSera Therapeutics LLC | 1 | $24.24 |
| Celgene Corporation BMY | 1 | $22.99 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.